1. Mishra SK

9789350252727

10.5005/jp/books/11216_8

1/e

2011

27

Anticancer molecules, investigational new drug (IND), tumor angiogenesis, hollow fiber assay, subcutaneous xenografts, breast carcinoma, lung carcinoma, glioma, methylthiazoldiphenyl tetrazolium (MTT) assay, colony-forming assay, tumor clonogenic assay (TCA), diagnostic biomarker, prognostic biomarker, phase 0 clinical trials, myelosuppression, mucositis, radiotherapy, drug discovery, NDA filing, COMPARE program, SF-268, LC50, Xenograft tumors, biomarkers, pharmacokinetics, toxicology studies, chemistry, manufacturing and control, emergency use IND, cytotoxic drugs, starting dose selection, surrogate end-points, anticancer agents, EORTC, progression free survival, complete response, fast track approval, orphan drug approvals, phase IV studies